* Prestige Consumer Healthcare Inc PBH.N PBH is expected
to show a rise in quarterly revenue when it reports results on
February 3.
* The Tarrytown New York-based company is expected to
report a
9.0% increase in revenue to $260.385 million from $238.79
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prestige Consumer
Healthcare Inc is for earnings of 88 cents per share. For the
same quarter last year, the company reported earnings of 81
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $68.5, about 17.6% above its last closing
price of $56.45.
*
This summary was machine generated February 1 at 17:13 GMT. All
figures in US dollars unless otherwise stated